DM
ANIP icon

Deerfield Management’s ANI Pharmaceuticals ANIP Stock Holding History

Deerfield Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,138
Closed -$327K – 456
2024
Q2 		$327K Buy
5,138
+511
+11% +$33.2K 0.01% 327
2024
Q1 		$320K Sell
4,627
-1,720
-27% -$104K 0.01% 241
2023
Q4 		$350K Buy
+6,347
New +$350K 0.01% 102
2014
Q4 		– Sell
-607,355
Closed -$17.2M – 115
2014
Q3 		$17.2M Hold
607,355
– – 0.63% 51
2014
Q2 		$20.9M Buy
607,355
+235,783
+63% +$7.39M 0.84% 42
2014
Q1 		$11.6M Buy
+371,572
New +$9.86M 0.48% 58

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Deerfield Management's ANIP Position: Q3 2024 in Review

Deerfield Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2024, closing a stake of 5,138 shares — an estimated $327K sold.

Deerfield Management first reported a position in ANIP in Q1 2014 and held it in 6 quarters. The position peaked at $20.9M in Q2 2014. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

  • Deerfield Management reported no remaining ANI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Deerfield Management sold 5,138 ANI Pharmaceuticals shares in Q3 2024, an estimated $327K.
  • Deerfield Management first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • Deerfield Management's ANI Pharmaceuticals position peaked at $20.9M in Q2 2014.
  • 208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.